We still have a Long Way to go to Effectively Deliver Genes!

  title={We still have a Long Way to go to Effectively Deliver Genes!},
  author={Daniele Pezzoli and Roberto Chiesa and Luigi De Nardo and Gabriele Candiani},
  journal={Journal of Applied Biomaterials \& Functional Materials},
  pages={82 - 91}
Gene therapy is emerging as a revolutionary alternative to conventional therapeutic approaches. However, its clinical application is still hampered by the lack of safe and effective gene delivery techniques. Among the plethora of diverse approaches used to ferry nucleic acids into target cells, non-viral vectors represent promising and safer alternatives to viruses and physical techniques. Both cationic lipids and polymers spontaneously wrap and shrink the genetic material in complexes named… 

Figures from this paper

Non-viral gene delivery strategies for gene therapy: a “ménage à trois” among nucleic acids, materials, and the biological environment

Smart vectors sensitive to a variety of physiological stimuli such as cell enzymes, redox status, and pH are substantially changing the landscape of gene delivery by helping to overcome some of the systemic and intracellular barriers that viral vectors naturally evade.

How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?

This review addresses some critical issues that need to be considered for clinical practice application of non-viral vectors in mainstream medicine, such as efficiency, biocompatibility, long-lasting effect, route of administration, design of experimental condition or commercialization process.

First Insights into Non-invasive Administration Routes for Non-viral Gene Therapy

The up-to-date and possible future strategies to improve DNA transfection efficiency using non-viral vectors and focusing on the non-invasive routes of administration are discussed, after briefly introducing the basis of gene therapy.

Application of Non-Viral Vectors in Drug Delivery and Gene Therapy

This review summarized a variety of non-viral vectors and carriers including polymers, liposomes, gold nanoparticles, mesoporous silica nanoparticles and carbon nanotubes from the aspects of physicochemical characteristics, synthesis methods, functional modifications, and research applications.

Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!

This review provides a catalog of conditions optimized for the gold standard and internal reference, 25 kDa polyethyleneimine, that can be profitably replicated across studies for the sake of comparison and pave the way for the implementation of standardized protocols in order to make the evaluation of the effectiveness of transfectants as unbiased as possible.

The role of the carrier and the endocytic pathway in non-viral gene delivery

It is suggested that the characterization of in vitro cell models for the expression and activity of specific endocytic pathways (endocytic profiling) would facilitate the interpretation of the data obtained in nanoparticle uptake studies.

Poly(amidoamine) dendrimer complexes as a platform for gene delivery

The conclusion is that dendrimers are promising candidates for gene delivery, but this is just the beginning and further studies are required before using them in human gene therapy.

Synthesis of multifunctional PAMAM-aminoglycoside conjugates with enhanced transfection efficiency.

A novel type of aminoglycoside-rich dendrimers with a defined structure based on polyamidoamine (PAMAM) in order to develop efficient, nontoxic gene delivery vehicles.



Cationic lipids, lipoplexes and intracellular delivery of genes.

  • L. WasunguD. Hoekstra
  • Biology, Chemistry
    Journal of controlled release : official journal of the Controlled Release Society
  • 2006

Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

Toxicity of cationic lipids and cationic polymers in gene delivery.

Gene delivery by lipoplexes and polyplexes.

Intelligent polymers as nonviral vectors

Intelligent polymers, also called as ‘stimuli responsive polymers’, have a great potential as nonviral vectors to obtain site-, timing-, and duration period-specific gene expression, which is already exhibited in recent studies that are briefly summarized here.

Nonviral vectors for gene delivery.

Two nonviral gene delivery systems using either biodegradable poly(D,Llactide-co-glycolide) (PLG) nanoparticles or cell penetrating peptide (CPP) complexes have been designed and studied using A549 human lung epithelial cells.

Gene therapy: The state of the art and future directions.

The purpose of this review is to give an overview of the current knowledge concerning the assembly of Lipoplexes and the trafficking of lipoplexes into cells, as well as to underscore the advantages and disadvantages of lipidic gene carriers among non-viral gene delivery systems.

Dimerizable Redox‐Sensitive Triazine‐Based Cationic Lipids for in vitro Gene Delivery

Introduction of a missing gene into the cell nucleus (transfection), followed by its expression by the natural machinery of the cell, is a very well-established strategy to produce proteins. This

Breaking up the correlation between efficacy and toxicity for nonviral gene delivery

Red reductive degradation is a highly promising tool for the design of new transfection materials because it produces mainly nontoxic fragments and substantially lower toxicities.

Directed evolution of novel adeno-associated viruses for therapeutic gene delivery

Progress is outlined in creating novel classes of AAV variant libraries and the successful isolation of variants with novel and advantageous in vitro and in vivo gene delivery properties are highlighted.